Loading company…
Revier Therapeutics develops drug candidates and research programs for heart and metabolic diseases.
Revier Therapeutics is a biotechnology company developing drug candidates and research programs for heart and metabolic diseases. Founded in 2023, it is based in Heidelberg, Germany.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in